The DOI matches its Crossref record.
Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial
Open accessAbstract
OBJECTIVE: To test whether a drug review and symptom self management and lifestyle advice intervention by community pharmacists could reduce hospital admissions or mortality in heart failure patients. DESIGN: Randomised controlled trial. SETTING: Home based intervention in heart failure patients. PARTICIPANTS: 293 patients diagnosed with heart failure were included (149 intervention, 144 control) after an emergency admission. INTERVENTION: Two home visits by one of 17 community pharmacists within two and eight weeks of discharge. Pharmacists reviewed drugs and gave symptom self management and lifestyle advice. Controls received usual care. MAIN OUTCOME MEASURES: The primary outcome was total hospital readmissions at six months. Secondary outcomes included mortality and quality of life (Minnesota living with heart failure questionnaire and EQ-5D). RESULTS: Primary outcome data were available for 291 participants (99%). 136 (91%) intervention patients received one or two visits. 134 admissions occurred in the intervention group compared with 112 in the control group (rate ratio=1.15, 95% confidence interval 0.89 to 1.48; P=0.28, Poisson model). 30 intervention patients died compared with 24 controls (hazard ratio=1.18, 0.69 to 2.03; P=0.54). Although EQ-5D scores favoured the intervention group, Minnesota living with heart failure questionnaire scores favoured controls; neither difference was statistically significant. CONCLUSION: This community pharmacist intervention did not lead to reductions in hospital admissions in contrast to those found in trials of specialist nurse led interventions in heart failure. Given that heart failure accounts for 5% of hospital admissions, these results present a problem for policy makers who are faced with a shortage of specialist provision and have hoped that skilled community pharmacists could produce the same benefits. TRIAL REGISTRATION NUMBER: ISRCTN59427925.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Feltner, C., Jones, C. D., Cené, C. W., Zheng, Z.-J., Sueta, C. A., Coker-Schwimmer, E. J. L., Arvanitis, M., Lohr, K. N., Middleton, J. C., & Jonas, D. E. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0083 · Cited by 681
Gillespie, U., Alassaad, A., Henrohn, D., Garmo, H., Hammarlund-Udenaes, M., Toss, H., Kettis-Lindblad, Å., Melhus, H., & Mörlin, C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.71 · Cited by 582
A review of health utilities using the EQ-5D in studies of cardiovascular disease
Dyer, M. T., Goldsmith, K. A., Sharples, L. S., & Buxton, M. J. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-13 · Cited by 420
Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?
Mc Namara, K., Alzubaidi, H., & Jackson, J. K. (2019) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s133088 · Cited by 410
Metadata
- Authors
- Holland, R., Brooksby, I., Lenaghan, E., Ashton, K., Hay, L., Smith, R., Shepstone, L., Lipp, A., Daly, C., Howe, A., Hall, R., & Harvey, I.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2007-04-23
- Volume
- 334
- Issue
- 7603
- Pages
- 1098
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2161374495
- Cited by
- 175
- References
- 0
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. https://app.cochat.ai/papers/10.1136/bmj.39164.568183.ae
- The paper
- Holland, R., Brooksby, I., Lenaghan, E., Ashton, K., Hay, L., Smith, R., Shepstone, L., Lipp, A., Daly, C., Howe, A., Hall, R., & Harvey, I. (2007). Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ. https://doi.org/10.1136/bmj.39164.568183.ae
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.